SHR-3167 Injection

DRUG3 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2Type 2 Diabetes

Phase 1

A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes

RecruitingNCT07032688

Jiangsu HengRui Medicine Co., Ltd.Type 2 Diabetes

Start: 2025-08-11End: 2027-04-01Target: 55Updated: 2026-04-17

A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

RecruitingNCT07489482

Jiangsu HengRui Medicine Co., Ltd.Diabetes Mellitus

Start: 2026-04-02End: 2026-12-01Target: 60Updated: 2026-04-29

Phase 2

A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents

Active, not recruitingNCT07472725

Jiangsu HengRui Medicine Co., Ltd.Diabetes Mellitus, Type 2

Start: 2026-04-11End: 2027-02-01Updated: 2026-06-04